Elixinol Wellness Limited (FRA:E8M)
Germany
· Delayed Price · Currency is EUR 0.0040
+0.0005 (14.29%)
At close: Dec 5, 2025
Elixinol Wellness Income Statement
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Revenue | 15.85 | 14.96 | 8.27 | 7.06 | 9.34 | 15.01 | Upgrade
|
| Revenue Growth (YoY) | 36.79% | 80.87% | 17.21% | -24.45% | -37.79% | -51.13% | Upgrade
|
| Cost of Revenue | 10.18 | 9.6 | 5 | 4.07 | 7.22 | 8.34 | Upgrade
|
| Gross Profit | 5.67 | 5.36 | 3.27 | 2.99 | 2.12 | 6.67 | Upgrade
|
| Selling, General & Admin | 9.76 | 8.78 | 8.58 | 12.28 | 18.82 | 29.07 | Upgrade
|
| Other Operating Expenses | 0.76 | 0.54 | -0.54 | -0.51 | -0.5 | -0.22 | Upgrade
|
| Operating Expenses | 11.24 | 10.41 | 9.31 | 12.74 | 20 | 31.77 | Upgrade
|
| Operating Income | -5.57 | -5.05 | -6.04 | -9.75 | -17.89 | -25.1 | Upgrade
|
| Interest Expense | -0.43 | -0.21 | -0.1 | -0.07 | -0.09 | -0.05 | Upgrade
|
| Interest & Investment Income | 0.01 | 0.03 | 0.21 | 0.02 | 0.05 | 0.1 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | - | -1.08 | Upgrade
|
| Currency Exchange Gain (Loss) | 0 | 0.01 | -0.01 | -0.04 | 0.08 | -0.07 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | -0.33 | -4.7 | Upgrade
|
| EBT Excluding Unusual Items | -5.99 | -5.22 | -5.94 | -9.84 | -18.18 | -30.9 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | - | -28.71 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.09 | -0.09 | -1.33 | - | - | -4.73 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0 | -0 | -0 | 0.03 | -0.08 | -0.26 | Upgrade
|
| Asset Writedown | -0.06 | - | -0.24 | -0.77 | -0.75 | -36.04 | Upgrade
|
| Other Unusual Items | - | - | - | 0.01 | 1.92 | 0.37 | Upgrade
|
| Pretax Income | -5.65 | -5.31 | -7.5 | -10.57 | -17.09 | -100.28 | Upgrade
|
| Income Tax Expense | -3.59 | -3.59 | 0 | 0 | -0.07 | 4.2 | Upgrade
|
| Earnings From Continuing Operations | -2.06 | -1.72 | -7.51 | -10.57 | -17.03 | -104.48 | Upgrade
|
| Net Income to Company | -2.06 | -1.72 | -7.51 | -10.57 | -17.03 | -104.48 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | - | -0.03 | Upgrade
|
| Net Income | -2.06 | -1.72 | -7.51 | -10.57 | -17.03 | -104.51 | Upgrade
|
| Net Income to Common | -2.06 | -1.72 | -7.51 | -10.57 | -17.03 | -104.51 | Upgrade
|
| Shares Outstanding (Basic) | 203 | 155 | 59 | 40 | 39 | 22 | Upgrade
|
| Shares Outstanding (Diluted) | 203 | 155 | 59 | 40 | 39 | 22 | Upgrade
|
| Shares Change (YoY) | 105.12% | 160.95% | 49.90% | 0.40% | 75.46% | 35.68% | Upgrade
|
| EPS (Basic) | -0.01 | -0.01 | -0.13 | -0.27 | -0.43 | -4.66 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.01 | -0.13 | -0.27 | -0.43 | -4.66 | Upgrade
|
| Free Cash Flow | -2.74 | -3.53 | -2.77 | -8.16 | -14.23 | -22.92 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.02 | -0.05 | -0.21 | -0.36 | -1.02 | Upgrade
|
| Gross Margin | 35.77% | 35.82% | 39.50% | 42.31% | 22.68% | 44.41% | Upgrade
|
| Operating Margin | -35.16% | -33.78% | -73.09% | -138.20% | -191.54% | -167.24% | Upgrade
|
| Profit Margin | -12.99% | -11.51% | -90.79% | -149.84% | -182.32% | -696.24% | Upgrade
|
| Free Cash Flow Margin | -17.26% | -23.60% | -33.50% | -115.62% | -152.40% | -152.67% | Upgrade
|
| EBITDA | -5.19 | -4.51 | -5.92 | -9.57 | -17.4 | -23.36 | Upgrade
|
| EBITDA Margin | -32.75% | -30.17% | -71.60% | -135.69% | -186.33% | -155.61% | Upgrade
|
| D&A For EBITDA | 0.38 | 0.54 | 0.12 | 0.18 | 0.49 | 1.75 | Upgrade
|
| EBIT | -5.57 | -5.05 | -6.04 | -9.75 | -17.89 | -25.1 | Upgrade
|
| EBIT Margin | -35.16% | -33.78% | -73.09% | -138.20% | -191.54% | -167.24% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.